Video

Addressing the gaps in AMD treatment

Author(s):

OT Staff Reports

Aleksandra Rachitskaya, MD, speaks on the current gaps in AMD treatment as well as ongoing retinal advancements to help address unmeet needs of patients.

Aleksandra Rachitskaya, MD, retinal specialist of the Cole Eye Institute, Cleveland Clinic,speaks on the current gaps in AMD treatment as well as ongoing retinal advancements in work to help address unmeet needs of patients.

See more AMD Awareness content here, here, and here.

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
Related Content
Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform
November 22nd 2024

Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

AlloVir and Kalaris Therapeutics announce all-stock merger to focus on retinal diseases
November 22nd 2024

AlloVir and Kalaris Therapeutics announce all-stock merger to focus on retinal diseases

EyePod podcast: Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)
November 1st 2024

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy
November 21st 2024

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy

Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for geographic atrophy
November 19th 2024

Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for geographic atrophy

© 2024 MJH Life Sciences

All rights reserved.